| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 12/12/2007 | EP1752452A9 Propane-1,3-dione derivative or its salt |
| 12/12/2007 | EP1644357B1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 12/12/2007 | EP1399443B1 Nitrogen-containing bicyclic heterocycles for use as antibacterials |
| 12/12/2007 | EP1327630B1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
| 12/12/2007 | CN101087781A Indole derivatives for treating pulmonary tuberculosis |
| 12/12/2007 | CN101087780A Tricyclic amino alcohols, processes for synthesis of same and use of same as anti-inflammatory drugs |
| 12/12/2007 | CN101087779A Selected benzofuran derivatives |
| 12/12/2007 | CN101087773A Inhibitors of c-fms kinase |
| 12/12/2007 | CN101087768A Thrombopoietin activity modulating compounds and methods |
| 12/12/2007 | CN101087766A Pyridazine compounds, compositions and methods |
| 12/12/2007 | CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 12/12/2007 | CN101085772A Compound with PPARgamma excitant activity and application thereof |
| 12/12/2007 | CN101085759A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 12/12/2007 | CN100354268C Novel triazolo pyrimidine compounds |
| 12/12/2007 | CN100354263C Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles |
| 12/12/2007 | CN100354262C Sterically hindered amine compound |
| 12/12/2007 | CN100353942C Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 12/11/2007 | US7307097 Chemical compounds |
| 12/11/2007 | US7307088 Substituted anthranilic amide derivatives and methods of use |
| 12/11/2007 | US7307087 Antidepressants; analgesics; antiinflammatory agents; side effect reduction |
| 12/11/2007 | US7307079 Treating acute and chronic pain and inflammatory, gastrointestinal, allergic, cardiovascular, skin, opthalmological, respiratory, nervous system, cognition and memory disorders, etc. |
| 12/11/2007 | US7307074 Diazepan derivatives or salts thereof |
| 12/11/2007 | US7307065 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents |
| 12/11/2007 | CA2393271C Retroviral protease inhibiting compounds |
| 12/06/2007 | WO2007140197A1 Therapeutic pyrrolidine compounds |
| 12/06/2007 | WO2007139968A2 Triazole compounds that modulate hsp90 activity |
| 12/06/2007 | WO2007139955A2 Triazole compounds that modulate hsp90 activity |
| 12/06/2007 | WO2007139499A1 Compounds for use as a medicament |
| 12/06/2007 | WO2007139464A1 Isoindole derivatives useful for treating pain, gastrointestinal diseases and cancer |
| 12/06/2007 | WO2007139230A1 Seven-membered ring compound, production method thereof and pharmaceutical use thereof |
| 12/06/2007 | WO2007139211A1 Process for production of optically active piperidine compound |
| 12/06/2007 | WO2007138994A1 Hsp90 inhibitor |
| 12/06/2007 | WO2007137980A1 Nitrated heterocyclic compounds as endothelin receptor antagonist |
| 12/06/2007 | WO2007137968A1 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist |
| 12/06/2007 | WO2007105053A3 Tetralines antagonists of the h-3 receptor |
| 12/06/2007 | WO2007047838A3 Process for preparing olmesartan medoxomil |
| 12/06/2007 | WO2006067428A3 1, 2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands |
| 12/06/2007 | US20070281956 Phenylpyrimidine amines as IgE inhibitors |
| 12/06/2007 | US20070281946 Tri(cyclo) substituted amide compounds |
| 12/06/2007 | US20070281944 Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 12/06/2007 | US20070281939 5-(3,5-Dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(1-hydroxy-cycloheptylmethyl)benzamide derivatives in which the triazine ring has various 4-substituents, e.g., carbamoylmethyl-, dimethylaminoethyl-, acetylaminoethyl-, and pyridinylmethyl-; treating rheumatoid arthritis |
| 12/06/2007 | US20070281936 To reducte the purinergic neurotransmission; Parkinson's disease; dyskinesias; Movement disorders; Adenosine receptors antagonists; 2-Methylamino-6-(5-methyl-2-furyl)-N-(2-pyridylmethyl)pyrimidine-4-carboxamide |
| 12/06/2007 | US20070281930 bicyclic bisamides for controlling acarina |
| 12/06/2007 | CA2659570A1 3-(1,3-benzodioxol-5-yl)-6-(4-cyclopropylpiperazin-1-yl)-pyridazine, itssalts and solvates and its use as histamine h3 receptor antagonist |
| 12/06/2007 | CA2653667A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 12/06/2007 | CA2653529A1 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 12/06/2007 | CA2653332A1 Triazole compounds that modulate hsp90 activity |
| 12/06/2007 | CA2653329A1 Triazole compounds that modulate hsp90 activity |
| 12/06/2007 | CA2653319A1 Hsp90 inhibitor |
| 12/06/2007 | CA2653223A1 Therapeutic pyrrolidine compounds |
| 12/06/2007 | CA2653222A1 Triazole compounds that modulate hsp90 activity |
| 12/06/2007 | CA2652636A1 Nitrated heterocyclic compounds as endothelin receptor antagonist |
| 12/05/2007 | EP1862463A1 Pyrimidine compound crystal or amorphous form and process for producing the same |
| 12/05/2007 | EP1862458A2 Therapeutic agents useful for treating pain |
| 12/05/2007 | EP1861399A2 Cgrp receptor antagonists |
| 12/05/2007 | EP1861393A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| 12/05/2007 | EP1861388A1 Potassium channel modulating agents and their medical use |
| 12/05/2007 | EP1861380A1 2-(4-oxo-4h-quinazolin-3-yl)acetamides and their use as vasopressin v3 antagonists |
| 12/05/2007 | EP1861378A1 N-aryl-sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents |
| 12/05/2007 | EP1861377A1 Benzimidazolone derivatives as cb2 receptor ligands |
| 12/05/2007 | EP1861365A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 12/05/2007 | EP1860942A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof |
| 12/05/2007 | EP1554262B1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 12/05/2007 | EP1433479B1 Appetite-stimulating agents and remedies for anorexia |
| 12/05/2007 | EP1208085B1 Benzanilides as potassium channel openers |
| 12/05/2007 | EP1169294B1 Pharmaceutical compounds |
| 12/05/2007 | CN101084216A Inhibitors for the soluble epoxide hydrolase |
| 12/05/2007 | CN101084198A Substituted amino-pyrimidones and uses thereof |
| 12/05/2007 | CN101084195A 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 12/05/2007 | CN101084189A Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 12/05/2007 | CN101081845A Substituted sulphone and sulphonamide compounds useful for the treatment of obesity, type II diabetes and cns disorders |
| 12/05/2007 | CN101081843A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 12/05/2007 | CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus |
| 12/05/2007 | CN100352817C Pyridinoylpiperidines as 5-HTLF agonists |
| 12/05/2007 | CN100352816C Nociceptin analogs |
| 12/05/2007 | CN100352808C Heterocyclic diamide invertebrate pest control agents |
| 12/05/2007 | CN100352807C Chemical compounds |
| 12/05/2007 | CN100352806C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 12/05/2007 | CN100352437C Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders |
| 12/04/2007 | US7304168 For tracing/imaging molecular transfer between cellular gap junctions |
| 12/04/2007 | US7304087 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 12/04/2007 | US7304086 Inhibitors of glutaminyl cyclase |
| 12/04/2007 | US7304083 2-iminoimidazole derivatives (2) |
| 12/04/2007 | US7304082 5-Anilino- or phenylalkylamino-3-furanylalkyl-4H-1,2,4-triazoles (ethyl 5-(5-phenylamino-4H-[1,2,4]triazol-3-ylsulfanylmethyl)-furan-2-carboxylate); type 2 methionine aminopeptidase inhibitors; antiproliferative agents |
| 12/04/2007 | US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 12/04/2007 | US7304078 Thrombosis; cardiovascular disorders; restenosis; hypotensive agents; antiarrhythmia agents; antiinflamamtroy agents; central nervous system disorders |
| 12/04/2007 | US7304077 Asthma, rhinitis therapy |
| 12/04/2007 | US7304072 Spiro compounds |
| 12/04/2007 | US7304071 stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant; 2-amino-4-(p-aminocarbonyl)phenyl-substituted pyrimidine compounds |
| 12/04/2007 | US7304063 Inhibitors of Akt activity |
| 12/04/2007 | US7304062 Peroxisome proliferator activated receptor alpha agonists |
| 12/04/2007 | US7304061 4-(5-Methyl-2-phenyl-pyrimidin-4-yl)-1H-pyrrole-2 carboxylic acid (2-hydroxy-1-(S)-phenyl-ethyl)-amide; Mitogen-activated protein kinase inhibitor; anticarcinogenic, antiinflammatory agent,neurodegenerative disorders, restenosis, antidiabetic, antiallergen, and cardiovascular disease |
| 12/04/2007 | US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment |
| 12/04/2007 | US7304059 Substituted quinazolin-4-ylamine analogues |
| 12/04/2007 | US7304056 N-(3-tetrahydrobenzodiazepinonyl)succamides: 2R,3S)N1-[1,3,4,5-tetrahydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,5-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; inhibit production of A beta -peptide, preventing neurological amyloid deposits; Alzheimer's disease |
| 12/04/2007 | US7304055 Succinoylamino lactams as inhibitors of Aβ protein production |
| 12/04/2007 | US7304053 Glycoprotein-mediated MDR |
| 12/04/2007 | US7304052 Irritable bowel syndrome; gastrointestinal disorders |
| 12/04/2007 | CA2424964C Nitrogen-containing 5-membered ring compound |
| 12/04/2007 | CA2280753C 1,4-substituted cyclic amine derivatives |